Assembly Biosciences, Inc. (ASMB) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Assembly Biosciences, Inc. (ASMB) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

ASMB Cash Flow Statement

Assembly Biosciences, Inc. (ASMB) cash flow statement — 18-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-15.49M	-22.1M	14.24M	-15.13M	-16.76M	-23.44M	-407K	-15.24M	-17.1M	-18.36M	73.65M	-13.85M	-13.63M	-23.43M	-19.25M	-19.82M	-17.89M	-27.5M	-19.36M	-18.88M
Operating CF Margin %	-115.81%	-269.05%	33.52%	-140.26%	-174.09%	-248.85%	-5.53%	-222.7%	-200.42%	-317.44%	1028.16%	-	-	-	-	-	-	-	-	-301.92%
Operating CF Growth %	7.58%	5.73%	3598.03%	0.73%	2.01%	-27.64%	-100.55%	-10.08%	-25.49%	21.62%	482.5%	30.14%	23.8%	14.81%	0.56%	-4.98%	17.99%	17.52%	23.38%	-277.36%
Net Income	-3.86M	-9.08M	22.09M	-9.2M	-10.2M	-8.82M	-10.34M	-9.61M	-11.15M	-9.08M	-10.96M	-14.42M	-16.9M	-18.95M	-22.39M	-23.14M	-24.46M	-23.09M	-60.26M	-18.8M
Depreciation & Amortization	20K	26K	32K	32K	32K	33K	32K	33K	32K	32K	84K	116K	126K	124K	124K	134K	120K	120K	120K	119K
Stock-Based Compensation	2.42M	1.12M	1.46M	1.67M	834K	712K	751K	797K	833K	739K	959K	1.14M	1.19M	1.83M	2.01M	1.56M	1.58M	1.44M	1.95M	1.59M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-525K	-585K	-627K	-422K	-160K	-289K	-240K	-490K	-606K	-905K	70K	503K	685K	803K	782K	880K	956K	1.04M	37.19M	1.05M
Working Capital Changes	-13.54M	-13.57M	-8.72M	-7.22M	-7.27M	-15.08M	9.38M	-5.97M	-6.21M	-9.15M	83.5M	-1.18M	1.27M	-7.24M	222K	753K	3.92M	-7.02M	1.64M	-2.84M
Change in Receivables	-371K	523K	-62K	-912K	0	0	0	0	43K	0	-43K	342K	375K	227K	302K	-723K	1K	-188K	433K	-472K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	-70K	-42K	-512K	940K	-132K	290K	-750K	534K	74K	266K	-297K	-146K	-320K	-1.27M	551K	-512K	1.05M	-1.25M	31K	-238K
Cash from Investing	-92.08M	-5.38M	21.22M	-158.27M	16.99M	6.59M	-6.7M	24.49M	5.11M	17.27M	-89.65M	18.88M	-8.37M	10M	16.56M	31.43M	9.6M	33.05M	-8.48M	20.07M
Capital Expenditures	0	-19K	-24K	-42K	0	0	0	0	-14K	-14K	-71K	-136K	-48K	0	0	-102K	0	0	-18K	0
CapEx % of Revenue	-	0.23%	0.06%	0.39%	-	-	-	-	0.16%	0.24%	0.99%	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	831K	0	379K	0	0	0	0	0	24K	0	0	0	1.5M	0	0	0	1.5M	0
Cash from Financing	108.73M	149K	456K	171.93M	357K	1.92M	17M	0	12.45M	0	9.19M	0	134K	4.49M	437K	0	177K	0	2.71M	10.05M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	108.73M	149K	456K	171.93M	357K	1.92M	16.9M	0	12.39M	0	9.14M	0	134K	4.49M	325K	0	0	0	2.6M	10.05M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	96K	0	59K	0	49K	0	0	0	112K	0	177K	0	114K	0
Net Change in Cash	1.17M	-27.33M	35.92M	-1.47M	593K	-14.93M	9.89M	9.24M	459K	-1.09M	-6.82M	5.03M	-21.86M	-8.94M	-2.25M	11.61M	-8.11M	5.55M	-25.13M	11.24M
Free Cash Flow	-15.49M	-22.12M	14.21M	-15.18M	-16.76M	-23.44M	-407K	-15.24M	-17.12M	-18.38M	73.58M	-13.98M	-13.68M	-23.43M	-19.25M	-19.92M	-17.89M	-27.5M	-19.38M	-18.88M
FCF Margin %	-115.81%	-269.28%	33.47%	-140.65%	-174.09%	-248.85%	-5.53%	-222.7%	-200.59%	-317.68%	1027.17%	-	-	-	-	-	-	-	-	-301.92%
FCF Growth %	7.58%	5.64%	3592.14%	0.45%	2.09%	-27.54%	-100.55%	-9.01%	-25.15%	21.56%	482.13%	29.81%	23.53%	14.81%	0.65%	-5.52%	17.99%	24.49%	28.27%	-277.36%
FCF per Share	-0.82	-1.31	1.27	-1.98	-2.19	-3.12	-0.06	-2.40	-3.03	-3.35	13.42	-3.19	-3.14	-5.51	-4.74	-4.11	-3.70	-5.71	-4.25	-4.14
FCF Conversion (FCF/Net Income)	4.02x	2.43x	0.64x	1.65x	1.64x	2.66x	0.04x	1.59x	1.53x	2.02x	-6.72x	0.96x	0.81x	1.24x	0.86x	0.86x	0.73x	1.19x	0.32x	1.00x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0